Biocitech technology park appoints Jean-François Boussard as CEO

09-Mar-2010 - France

Biocitech SAS announced that its board has appointed Jean-François Boussard as CEO with effect from April 1st. Jean-François Boussard replaces Jacques Lhomel, who is taking retirement to pursue a number of personal projects.

Jean-François Boussard, 58, joins Biocitech after a long and successful biotechnology career in both academic and industry fields. From 1994, after six years as Patents, Licensing and Legal Director in a financial holding company, he was an independent consultant in enterprise creation and technology transfer. In 1998, he founded and was CEO of Substrat, a consulting company specialized in enterprise creation and management, project management and technology transfer in the field of biotechnology. His experience at Substrat, which plans to name its new CEO in the next few weeks, makes him exceptionally well qualified to take over the CEO position at Biocitech. Prior to Substrat, Jean-François Boussard was a manager for pharmaceuticals and biotechnology at France's innovation agency, Anvar, from 1982 to 1988. From 1979-82, he was a biologist at LERS Synthelabo after an earlier spell as a research scientist at the University of Metz. He completed a thesis in ecotoxicology at the University of Metz.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances